Penumbra Stock Price and Value Analysis

Should you buy Penumbra stock? (NYSE:PEN). Let's see how it does in our automated value investing analysis system.

  • This company is making money at a modest rate.
  • This company is less known than others.
  • This stock looks overpriced.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the PEN Numbers

PEN Price
(Penumbra stock price per share)
[?] PEN Fair Price
(based on intrinsic value)
[?] PEN Safety Price (based on a variable margin of safety) $0.00
[?] PE Ratio versus Sector 790% higher than other Healthcare stocks
[?] PE Ratio versus Industry 0% lower than other Medical Devices stocks
[?] Free Cash Flow Jitter 86%

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 2,366,226 shares shorted. With 35,791,624 shares available for purchase and an average trading volume over the past 10 trading days of 469,290, it would take at least 5.042 days for all of the short holders to cover their shorts.

Is Penumbra Stock on Sale?

We believe that Penumbra may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Penumbra looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy PEN Stock?

Does Penumbra have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.